» Articles » PMID: 23497411

A Bipolar Disorder Patient Becoming Asymptomatic After Adjunctive Anti-filiarasis Treatment: a Case Report

Overview
Journal BMC Psychiatry
Publisher Biomed Central
Specialty Psychiatry
Date 2013 Mar 19
PMID 23497411
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Evidence suggests that neurotropic infectious agents might be involved in bipolar disorder. So far, few have been written for the association between parasitic infection and bipolar disorder. Filariasis is a parasitic disease acting ruthlessly via mosquitos and affecting more than 120 million people worldwide. We present here, to our knowledge, the first description of a filariasis infected manic bipolar disorder patient fully improved in terms of psychiatric symptoms by anti-heminthic treatment.

Case Presentation: The patient is a 31 years-old man native of Congo. At inclusion, he presented a severe manic episode with dangerous behaviour unresolved by classic treatments. A diagnosis of filariasis bancrofti infection was made after the discovery of a systemic hypereosinophilia. Therefore, a bi-therapy of anthelmintics was conducted allowing a successful improvement with clear reduction of agitation and aggressive behaviours that could not be attributed to a modification of psychotropic treatments or filarial encephalopathy or acute disseminated encephalomyelitis.

Conclusion: The ineffectiveness of psychotropic treatment of a manic episode requires the evaluation of co-morbid medical conditions such as infections which can interfere with adequate mood stabilizing medication. Filariasis by inducing chronic inflammation and immunopathologic reactions seems to play a major role in infected affective disorders patients by changing levels of cytokines of the Th1 system or indirectly damaging the brain tissue. The beneficial combination of antihelmintics and mood stabilizers, in this case, could be explained by the potential of such association to downregulate neuroinflammation and excitotoxicity processes.Altogether, these data pinpoint the requirement to explore the parasitic infectious status in case of bipolar disorder patients resistant to classic treatments and originating or living in endemic geographical areas.

Citing Articles

Microbes and Mental Illness: Past, Present, and Future.

Bransfield R, Mao C, Greenberg R Healthcare (Basel). 2024; 12(1).

PMID: 38200989 PMC: 10779437. DOI: 10.3390/healthcare12010083.


[Autoimmune encephalitis-Diagnostic and therapeutic decision tree from a psychiatric, neurological and ethico-legal point of view : Approach in cases of lack of ability to give consent and permissibility of compulsory treatment].

Pruss H, Kohler S, Muller S Nervenarzt. 2019; 91(2):122-130.

PMID: 31538211 DOI: 10.1007/s00115-019-00802-1.

References
1.
Kenney M, Hewitt R . Psychoneurotic disturbances in filariasis, and their relief by removal of adult worms or treatment with hetrazan. Am J Trop Med Hyg. 1950; 30(6):895-9. DOI: 10.4269/ajtmh.1950.s1-30.895. View

2.
Hamdani N, Tamouza R, Leboyer M . Immuno- inflammatory markers of bipolar disorder: a review of evidence. Front Biosci (Elite Ed). 2011; 4(6):2170-82. DOI: 10.2741/e534. View

3.
Lopes R, Rodrigues R, Domingues I, Curral R, Roma-Torres A . [Antibiomania: a case of a manic episode induced by clarithromycin]. Acta Med Port. 2012; 24(5):827-32. View

4.
Bou Khalil R . Is there any place for macrolides in mood disorders?. Med Hypotheses. 2011; 78(1):86-7. DOI: 10.1016/j.mehy.2011.09.046. View

5.
Bode L, Dietrich D, Stoyloff R, Emrich H, Ludwig H . Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression. Lancet. 1997; 349(9046):178-9. DOI: 10.1016/S0140-6736(05)60979-8. View